Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Crossref DOI link:
Published Online: 2016-05-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bazzi, Zainab A.
Porter, Lisa A.
Boffa, Michael B.
Funding for this research was provided by:
Windsor Essex County Cancer Centre Foundation